The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

ADHD is a widely misunderstood condition. Knowing what ADHD is, and what it isn’t, can raise awareness of the condition and ...

SaveHealth reports that choosing ADHD medications involves understanding stimulant vs. nonstimulant types, side effects, ...

Stimulants act fast, and nonstimulants offer steadier effects. So what are the best ADHD medications for adults? Experts explain the options.

ADHD (Attention-Deficit/Hyperactivity Disorder), is a real brain-based condition that affects millions of children and adults ...

Drugmaker GSK said on Tuesday that Exdensur (depemokimab), an ultra-long-acting biologic to treat respiratory diseases, has ...

The most common side effects of NUCALA include: headache, injection site reactions (pain, redness, swelling, itching, or a ...

There is no scientific evidence base for routine use of multiple psychiatric drugs, particularly for children.

Gov. Tina Kotek announced a $65 million investment to add 146 new behavioral health treatment beds across Oregon. This effort ...

A largescale, comprehensive study has found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at ...

Learn how to avoid and address ADHD burnout effectively, with tips like prioritizing tasks, taking breaks, seeking coaching, and practicing self-compassion.